{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:09:45Z","timestamp":1773659385007,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI124769"],"award-info":[{"award-number":["AI124769"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI129594"],"award-info":[{"award-number":["AI129594"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI130197"],"award-info":[{"award-number":["AI130197"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH REACH program"],"award-info":[{"award-number":["NIH REACH program"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL150852"],"award-info":[{"award-number":["U01HL150852"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011132","name":"Rutgers, The State University of New Jersey","doi-asserted-by":"publisher","award":["New Jersey Medical School Startup funding"],"award-info":[{"award-number":["New Jersey Medical School Startup funding"]}],"id":[{"id":"10.13039\/100011132","id-type":"DOI","asserted-by":"publisher"}]},{"name":"RBHS-NJMS-Leica TCS SP8 STED","award":["1S10OD025182-01A1"],"award-info":[{"award-number":["1S10OD025182-01A1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The novel SARS-CoV-2 has quickly become a global pandemic since the first reported case in December 2019, with the virus infecting millions of people to date. The spike (S) protein of the SARS-CoV-2 virus plays a key role in binding to angiotensin-converting enzyme 2 (ACE2), a host cell receptor for SARS-CoV-2. S proteins that are expressed on the cell membrane can initiate receptor-dependent syncytia formation that is associated with extensive tissue damage. Formation of syncytia have been previously observed in cells infected with various other viruses (e.g., HIV, Ebola, Influenza, and Herpesviruses). However, this phenomenon is not well documented and the mechanisms regulating the formation of the syncytia by SARS-CoV-2 are not fully understood.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, we investigated the possibility that cell fusion events mediated by the S protein of SARS-CoV-2 and ACE2 interaction can occur in different human cell lines that mimic different tissue origins. These cell lines were transduced with either wild-type (WT-S) S protein or a mutated variant where the ER-retention motif was removed (\u039419-S), as well as human ACE2 expression vectors. Different co-culture combinations of spike-expressing 293T, A549, K562, and SK-Hep1 cells with hACE2-expressing cells revealed cell hybrid fusion. However, only certain cells expressing S protein can form syncytial structures as this phenomenon cannot be observed in all co-culture combinations. Thus, SARS-CoV-2 mediated cell\u2013cell fusion represents a cell type-dependent process which might rely on a different set of parameters. Recently, the \u039419-S variant is being widely used to increase SARS-CoV-2 pseudovirus production for in vitro assays. Comparison of cell fusion occurring via \u039419-S expressing cells shows defective nuclear fusion and syncytia formation compared to WT-S.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This distinction between the \u039419-S variant and WT-S protein may have downstream implications for studies that utilize pseudovirus-based entry assays. Additionally, this study suggest that spike protein expressed by vaccines may affect different ACE2-expressing host cells after SARS-CoV-2 vaccine administration. The long-term effects of these vaccines should be monitored carefully. \u039419-S mRNA may represent a safer mRNA vaccine design in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13578-021-00626-0","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T08:04:21Z","timestamp":1624435461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell\u2013cell fusion"],"prefix":"10.1186","volume":"11","author":[{"given":"Xuening","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsiung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saiaditya","family":"Badeti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Naghizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7295-8088","authenticated-orcid":false,"given":"Dongfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"issue":"9","key":"626_CR1","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin. 2020;41(9):1141\u20139.","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"626_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271\u201380.","journal-title":"Cell"},{"issue":"9","key":"626_CR3","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1128\/JVI.02232-10","volume":"85","author":"I Glowacka","year":"2011","unstructured":"Glowacka I, Bertram S, Muller MA, Allen P, Soilleux E, Pfefferle S, Steffen I, Tsegaye TS, He Y, Gnirss K, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011;85(9):4122\u201334.","journal-title":"J Virol"},{"issue":"3","key":"626_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","volume":"7","author":"L Du","year":"2009","unstructured":"Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S. The spike protein of SARS-CoV\u2013a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7(3):226\u201336.","journal-title":"Nat Rev Microbiol"},{"key":"626_CR5","doi-asserted-by":"publisher","first-page":"118056","DOI":"10.1016\/j.lfs.2020.118056","volume":"257","author":"A Sternberg","year":"2020","unstructured":"Sternberg A, Naujokat C. Structural features of coronavirus SARS-CoV-2 spike protein: targets for vaccination. Life Sci. 2020;257:118056.","journal-title":"Life Sci"},{"issue":"2","key":"626_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281\u201392.","journal-title":"Cell"},{"issue":"11","key":"626_CR7","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1128\/JVI.78.11.5913-5922.2004","volume":"78","author":"E Lontok","year":"2004","unstructured":"Lontok E, Corse E, Machamer CE. Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site. J Virol. 2004;78(11):5913\u201322.","journal-title":"J Virol"},{"key":"626_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms21186790","volume":"21","author":"A Samidurai","year":"2020","unstructured":"Samidurai A, Das A. Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies. Int J Mol Sci. 2020;21:18.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"626_CR9","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1152\/ajpheart.00618.2005","volume":"289","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Trask AJ, Jessup JA, Physiology C. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1\u20137) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol. 2005;289(6):2281\u201390.","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"4","key":"626_CR10","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","volume":"181","author":"Q Wang","year":"2020","unstructured":"Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, Lu G, Qiao C, Hu Y, Yuen KY, et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020;181(4):894\u2013904.","journal-title":"Cell"},{"key":"626_CR11","first-page":"578","volume":"4","author":"BF Hornich","year":"2021","unstructured":"Hornich BF, Grosskopf AK, Schlagowski S, Tenbusch M, Kleine-Weber H, Neipel F, Stahl-Hennig C, Hahn AS. SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation. J Virol. 2021;4:578.","journal-title":"J Virol"},{"key":"626_CR12","first-page":"65","volume":"2","author":"WA Mohler","year":"2013","unstructured":"Mohler WA. Cell\u2013cell fusion: transient channels leading to plasma membrane merger. Landes Biosci. 2013;2:65.","journal-title":"Landes Biosci."},{"issue":"7","key":"626_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrm1678","volume":"6","author":"BM Ogle","year":"2005","unstructured":"Ogle BM, Cascalho M, Platt JL. Biological implications of cell fusion. Nat Rev Mol Cell Biol. 2005;6(7):567\u201375.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"626_CR14","doi-asserted-by":"crossref","unstructured":"Ma M, Badeti S, Geng K, Liu D. Efficacy of targeting SARS-CoV-2 by CAR-NK cells. bioRxiv. 2020.","DOI":"10.1101\/2020.08.11.247320"},{"key":"626_CR15","first-page":"369","volume-title":"Multi-scale cell instance segmentation with keypoint graph based bounding boxes","author":"J Yi","year":"2019","unstructured":"Yi J, Wu P, Huang Q, Qu H, Liu B, Hoeppner DJ, Metaxas DN. Multi-scale cell instance segmentation with keypoint graph based bounding boxes. In: International conference on medical image computing and computer-assisted intervention, Berlin: Springer; 2019. p. 369\u201377."},{"key":"626_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.media.2019.05.004","volume":"55","author":"J Yi","year":"2019","unstructured":"Yi J, Wu P, Jiang M, Huang Q, Hoeppner DJ, Metaxas DN. Attentive neural cell instance segmentation. Med Image Anal. 2019;55:228\u201340.","journal-title":"Med Image Anal"},{"issue":"1","key":"626_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ijc.2910170110","volume":"17","author":"M Lieber","year":"1976","unstructured":"Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976;17(1):62\u201370.","journal-title":"Int J Cancer"},{"key":"626_CR18","volume-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","author":"CB Lozzio","year":"1975","unstructured":"Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Berlin: Springer; 1975."},{"issue":"2","key":"626_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ijc.2910230202","volume":"23","author":"LC Andersson","year":"1979","unstructured":"Andersson LC, Nilsson K, Gahmberg CG. K562\u2014a human erythroleukemic cell line. Int J Cancer. 1979;23(2):143\u20137.","journal-title":"Int J Cancer."},{"key":"626_CR20","first-page":"874","volume":"9","author":"T Marjot","year":"2021","unstructured":"Marjot T, Webb GJ, Barritt AS, Moon AM, Stamataki Z, Wong VW, Barnes E. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol. 2021;9:874.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"10","key":"626_CR21","doi-asserted-by":"publisher","first-page":"6558","DOI":"10.1074\/jbc.M114.623181","volume":"290","author":"N Kondo","year":"2015","unstructured":"Kondo N, Marin M, Kim JH, Desai TM, Melikyan GB. Distinct requirements for HIV-cell fusion and HIV-mediated cell-cell fusion. J Biol Chem. 2015;290(10):6558\u201373.","journal-title":"J Biol Chem"},{"issue":"2","key":"626_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/0042-6822(80)90307-4","volume":"107","author":"GT Lee","year":"1980","unstructured":"Lee GT, Spear PG. Viral and cellular factors that influence cell fusion induced by herpes simplex virus. Virology. 1980;107(2):402\u201314.","journal-title":"Virology"},{"issue":"7","key":"626_CR23","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3390\/v4071144","volume":"4","author":"BS Hamilton","year":"2012","unstructured":"Hamilton BS, Whittaker GR, Daniel S. Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion. Viruses. 2012;4(7):1144\u201368.","journal-title":"Viruses"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00626-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-021-00626-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00626-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T08:17:16Z","timestamp":1624436236000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-021-00626-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1186\/s13578-021-00626-0","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"assertion":[{"value":"30 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}